Recursion Pharmaceuticals ( ($RXRX) ) has provided an update. Recursion Pharmaceuticals announced significant leadership changes effective January ...

Achieved $30 million milestone from Roche and Genentech for delivering a whole-genome map of microglial immune cells—the second neuro map ...

Google launched its new video model Veo 3.1 with improved audio output, granular editing controls, and better output for image to video. It said that Veo 3.1 builds on May’s Veo 3 release and ...

No other artist has ever had every song from an album appear in an unbroken streak at the top of the Hot 10 — no skips. Swift had previously become the first and only artist ever to command all 10 ...

Recursion Pharmaceuticals trades at a $2.65bn valuation despite slow clinical progress, high cash burn, and no late-stage assets. RXRX's AI-driven drug discovery model is ambitious, but pipeline value ...

The U.S. military has killed at least 21 people in recent strikes on small boats that it says were smuggling drugs off the coast of Venezuela. President Trump justified the attacks by saying the ...

Peter Gratton, Ph.D., is a New Orleans-based editor and professor with over 20 years of experience in investing, risk management, and public policy. Peter began covering markets at Multex (Reuters) ...

Current political and economic issues succinctly explained. Sign up to receive CFR President Mike Froman’s analysis on the most important foreign policy story of the week, delivered to your inbox ...

The racing community has paid tribute to one of its own following the sad passing of Warren Huntly. Huntly was not only a respected form analyst but a friend and mentor to many in the racing industry, ...

Amid an influx of new residents and continued growth, Dallas’ once-sleepy suburban communities in Collin County are emerging as regional focal points. Roads and homes can’t be built fast enough, and ...

Recursion Pharmaceuticals (RXRX) shares ended the last trading session 8.2% higher at $5.52. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the ...